Influence of infusion method of rocuronium on pharmacokinetics and pharmacodynamics of rocuronium

Influence of infusion method of rocuronium on pharmacokinetics and pharmacodynamics of rocuronium - Influence of infusion method of rocuronium on pharmacokinetics and pharmacodynamics of rocuronium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006219

Enrollment

Registered

2011-08-23

Start date

2011-04-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patient undergoing elective surgery under general anesthesia

Interventions

rocuronium 0.6 mg/kg is administered at 1 mg/kg/min followed by rocuronium administration between 5 to 15 mcg/kg/min rocuronium 0.6 mg/kg is administered at 0.75 mg/kg/min followed by rocuronium admin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients undergoing elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: significant heart, respiratory, hepatic, or renal impairment; neuromuscular disease; body mass index greater than 30

Design outcomes

Primary

Measure	Time frame
pharmacodynamic effect of neuromuscular blockade	—

Countries

Japan

Contacts

Public ContactKenichi Masui

National Defense Medical College Department of Anesthesiology

kenichi@masuinet.com04-2995-1511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026